BlackRock Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $296K | Buy |
24,201
+1,381
| +6% | +$16.9K | ﹤0.01% | 2449 |
|
2016
Q3 | $269K | Buy |
22,820
+2,106
| +10% | +$24.8K | ﹤0.01% | 2464 |
|
2016
Q2 | $180K | Buy |
20,714
+615
| +3% | +$5.34K | ﹤0.01% | 2616 |
|
2016
Q1 | $106K | Buy |
20,099
+1,033
| +5% | +$5.45K | ﹤0.01% | 2845 |
|
2015
Q4 | $148K | Sell |
19,066
-9,688
| -34% | -$75.2K | ﹤0.01% | 2690 |
|
2015
Q3 | $226K | Buy |
28,754
+564
| +2% | +$4.43K | ﹤0.01% | 2621 |
|
2015
Q2 | $255K | Buy |
28,190
+829
| +3% | +$7.5K | ﹤0.01% | 2622 |
|
2015
Q1 | $355K | Buy |
27,361
+4,083
| +18% | +$53K | ﹤0.01% | 2302 |
|
2014
Q4 | $317K | Sell |
23,278
-1,949
| -8% | -$26.5K | ﹤0.01% | 2299 |
|
2014
Q3 | $226K | Sell |
25,227
-332
| -1% | -$2.97K | ﹤0.01% | 2507 |
|
2014
Q2 | $346K | Sell |
25,559
-1,034
| -4% | -$14K | ﹤0.01% | 2251 |
|
2014
Q1 | $264K | Buy |
26,593
+2,289
| +9% | +$22.7K | ﹤0.01% | 2465 |
|
2013
Q4 | $323K | Buy |
24,304
+1,848
| +8% | +$24.6K | ﹤0.01% | 2330 |
|
2013
Q3 | $273K | Sell |
22,456
-602,054
| -96% | -$7.32M | ﹤0.01% | 2333 |
|
2013
Q2 | $6.46M | Buy |
+624,510
| New | +$6.46M | 0.01% | 886 |
|